Loading organizations...
Loading organizations...
Developer of genetic medicines for neurological disorders.
Neurogene has raised $183.5M across 2 funding rounds.
Neurogene has raised $183.5M in total across 2 funding rounds.
Neurogene has raised $183.5M in total across 2 funding rounds.
Neurogene's investors include Oleg Nodelman, Alexandria Venture Investments, ArrowMark Partners, Ascendant BioCapital, Avidity Partners, BlackRock, Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Redmile Group, Samsara BioCapital, EcoR1 Capital.
Neurogene has raised $183.5M across 2 funding rounds. Most recently, it raised $115.0M Series B in December 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 16, 2020 | $115.0M Series B | Oleg Nodelman | Alexandria Venture Investments, ArrowMark Partners, Ascendant BioCapital, Avidity Partners, BlackRock, Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Redmile Group, Samsara BioCapital |
| Feb 12, 2019 | $68.5M Series A | Cormorant Asset Management, EcoR1 Capital, Redmile Group, Samsara BioCapital |